A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple MyelomaHanlon Sia,Peter T. Tan,Joshua Richter,Phoebe Joy Ho,Tara Cochrane,Hang Quach,Binod Dhakal,Igor Proscurshim, Tony Jiang, Emaryn Mancino,Yacine Salhi,Sammicheli Stefano, Girish Gudi,Andrew Garton,Eric J. Feldman,Andrew SpencerBlood（2022）引用 2|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
